Antivirals blocking entry of enteroviruses and therapeutic potential
Open Access
- 15 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Biomedical Science
- Vol. 28 (1), 1-12
- https://doi.org/10.1186/s12929-021-00708-8
Abstract
Viruses from the genus Enterovirus (EV) of the Picornaviridae family are known to cause diseases such as hand foot and mouth disease (HFMD), respiratory diseases, encephalitis and myocarditis. The capsid of EV is an attractive target for the development of direct-acting small molecules that can interfere with viral entry. Some of the capsid binders have been evaluated in clinical trials but the majority have failed due to insufficient efficacy or unacceptable off-target effects. Furthermore, most of the capsid binders exhibited a low barrier to resistance. Alternatively, host-targeting inhibitors such as peptides derived from the capsid of EV that can recognize cellular receptors have been identified. However, the majority of these peptides displayed low anti-EV potency (µM range) as compared to the potency of small molecule compounds (nM range). Nonetheless, the development of anti-EV peptides is warranted as they may complement the small-molecules in a drug combination strategy to treat EVs. Lastly, structure-based approach to design antiviral peptides should be utilized to unearth potent anti-EV peptides.Keywords
Funding Information
- Kementerian Pendidikan Malaysia (FRGS/1/2018/SKK11/SYUC/03/3)
- Sunway University (STR-RCTR-CVVR-01-2020)
This publication has 110 references indexed in Scilit:
- Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073Antimicrobial Agents and Chemotherapy, 2012
- Symmetry-Related Clustering of Positive Charges Is a Common Mechanism for Heparan Sulfate Binding in EnterovirusesJournal of Virology, 2012
- A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral ActivityPLOS ONE, 2012
- Human SCARB2-Dependent Infection by Coxsackievirus A7, A14, and A16 and Enterovirus 71Journal of Virology, 2012
- Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1PLOS ONE, 2012
- Ex Vivo and In Vivo Inhibition of Human Rhinovirus Replication by a New Pseudosubstrate of Viral 2A ProteaseJournal of Virology, 2012
- In Vitro Antiviral Activity of V-073 against PoliovirusesAntimicrobial Agents and Chemotherapy, 2009
- Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307Antimicrobial Agents and Chemotherapy, 2009
- Crystal structure of CD155 and electron microscopic studies of its complexes with poliovirusesProceedings of the National Academy of Sciences of the United States of America, 2008
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences of the United States of America, 1994